After US approval, Japan approves Leqembi, first Alzheimer's

Japan's health ministry has approved Leqembi, a drug for Alzheimer’s disease that was jointly developed by Japanese and U.S. pharmaceutical companies.

Related Keywords

Japan , Japanese , Fumio Kishida , Haruo Naito , Drug Administration , Eisai Co , Biogen Inc , Minister Fumio Kishida , Kyodo News , Alzheimer 039 S , Fda , Ealth Amp Science ,